Lucira Health Inc. [NASDAQ: LHDX] price surged by 13.45 percent to reach at $0.02. The company report on February 22, 2023 that Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
No debtor-in-possession financing required as the Company intends to fund operations and the sale process with available cash on hand.
A sum of 46841742 shares traded at recent session while its average daily volume was at 6.24M shares. Lucira Health Inc. shares reached a high of $0.181 and dropped to a low of $0.12 until finishing in the latest session at $0.14.
The average equity rating for LHDX stock is currently 3.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Lucira Health Inc. [LHDX]:
William Blair have made an estimate for Lucira Health Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on May 04, 2021. The new note on the price target was released on April 13, 2021, representing the official price target for Lucira Health Inc. stock.
The Average True Range (ATR) for Lucira Health Inc. is set at 0.06, with the Price to Sales ratio for LHDX stock in the period of the last 12 months amounting to 0.02. The Price to Book ratio for the last quarter was 0.09, with the Price to Cash per share for the same quarter was set at 1.11.
LHDX Stock Performance Analysis:
Lucira Health Inc. [LHDX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -48.28. With this latest performance, LHDX shares dropped by -56.25% in over the last four-week period, additionally sinking by -93.00% over the last 6 months – not to mention a drop of -96.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LHDX stock in for the last two-week period is set at 33.99, with the RSI for the last a single of trading hit 28.93, and the three-weeks RSI is set at 37.09 for Lucira Health Inc. [LHDX]. The present Moving Average for the last 50 days of trading for this stock 0.2797, while it was recorded at 0.1933 for the last single week of trading, and 1.3292 for the last 200 days.
Insight into Lucira Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Lucira Health Inc. [LHDX] shares currently have an operating margin of -68.45 and a Gross Margin at +11.46. Lucira Health Inc.’s Net Margin is presently recorded at -69.67.
Return on Equity for this stock declined to -52.37, with Return on Assets sitting at -38.46.
Lucira Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.50.
LHDX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LHDX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lucira Health Inc. go to 9.80%.
Lucira Health Inc. [LHDX] Insider Position Details
There are presently around $1 million, or 57.10% of LHDX stock, in the hands of institutional investors. The top three institutional holders of LHDX stocks are: ECLIPSE VENTURES, LLC with ownership of 6,223,795, which is approximately 0% of the company’s market cap and around 3.40% of the total institutional ownership; EPIQ CAPITAL GROUP, LLC, holding 725,675 shares of the stock with an approximate value of $0.1 million in LHDX stocks shares; and VANGUARD GROUP INC, currently with $87000.0 in LHDX stock with ownership of nearly -1.31% of the company’s market capitalization.
Positions in Lucira Health Inc. stocks held by institutional investors increased at the end of Thursday and at the time of the Thursday reporting period, where 9 institutional holders increased their position in Lucira Health Inc. [NASDAQ:LHDX] by around 189,525 shares. Additionally, 16 investors decreased positions by around 13,689,954 shares, while 9 investors held positions by with 4,503,075 shares. The mentioned changes placed institutional holdings at 9,376,404 shares, according to the latest SEC report filing. LHDX stock had 5 new institutional investments in for a total of 141,886 shares, while 5 institutional investors sold positions of 376,873 shares during the same period.